The Japanese Inflammatory Bowel Disease Research Group proposed a set of consensus statements in 2007, updated again in 2014, to address growing low-level evidence supporting the use of anti-TNF therapy [11, 12]. This evidence concerns the gene TNF and inflammatory bowel disease.